Sodium ((2R,3S,4R,5R)-5-(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)-3,4-dihydroxytetrahydrofuran-2-yl)methyl hydrogenphosphate
95%
- Product Code: 235050
CAS:
3106-18-1
Molecular Weight: | 346.16 g./mol | Molecular Formula: | C₉H₁₂N₂NaO₉P |
---|---|---|---|
EC Number: | MDL Number: | ||
Melting Point: | Boiling Point: | ||
Density: | Storage Condition: | 2-8°C |
Product Description:
Used as an intermediate in the synthesis of antiviral and anticancer agents, particularly in the development of nucleoside analogs. It plays a key role in prodrug strategies, enhancing cellular uptake and phosphorylation of active compounds. Commonly employed in the preparation of modified nucleotides for therapeutic use, including treatments for hepatitis B, HIV, and certain cancers. Its structure supports targeted delivery and improved metabolic stability in pharmaceutical formulations.
Sizes / Availability / Pricing:
Size | Availability | Price | Quantity |
---|---|---|---|
50mg | 10-20 days | ฿380.00 |
+
-
|
Sodium ((2R,3S,4R,5R)-5-(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)-3,4-dihydroxytetrahydrofuran-2-yl)methyl hydrogenphosphate
Used as an intermediate in the synthesis of antiviral and anticancer agents, particularly in the development of nucleoside analogs. It plays a key role in prodrug strategies, enhancing cellular uptake and phosphorylation of active compounds. Commonly employed in the preparation of modified nucleotides for therapeutic use, including treatments for hepatitis B, HIV, and certain cancers. Its structure supports targeted delivery and improved metabolic stability in pharmaceutical formulations.
Mechanism | - |
Appearance | - |
Longevity | - |
Strength | - |
Storage | - |
Shelf Life | - |
Allergen(s) | - |
Dosage (Range) | - |
Recommended Dosage | - |
Dosage (Per Day) | - |
Recommended Dosage (Per Day) | - |
Mix Method | - |
Heat Resistance | - |
Stable in pH range | - |
Solubility | - |
Product Types | - |
INCI | - |
Purchase History for
Loading purchase history...
Cart
No products
Subtotal:
฿0.00
฿0.00
Total :